ZBIO · Company research
Zenas BioPharma, Inc. Common Stock (ZBIO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
12records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| COVID vaccination produced immune responses in all 4 participants during a planned treatment break - Stock Titan | COVID vaccination produced immune responses in all 4 participants during a planned treatment break Stock Titan | View source ↗ | Stock Titan | Oct 12, 2026 | neutral | 0 | 0.6 |
| Zenas BioPharma Stock Is Down 6.9% Has The Bull Case Changed After Trial Updates - Simply Wall Street | Zenas BioPharma Stock Is Down 6.9% Has The Bull Case Changed After Trial Updates Simply Wall Street | View source ↗ | Simply Wall Street | Oct 9, 2026 | neutral | 0 | 0.6 |
| Understanding the Setup: (ZBIO) and Scalable Risk - Stock Traders Daily | Understanding the Setup: (ZBIO) and Scalable Risk Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 8, 2026 | neutral | 0 | 0.6 |
| A lupus drug and an oral treatment feature in Zenas’ Oct. 27 research event. - Stock Titan | A lupus drug and an oral treatment feature in Zenas’ Oct. 27 research event. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| Zenas BioPharma: Obexelimab Is Being Graded On The Wrong Curve (NASDAQ:ZBIO) - Seeking Alpha | Zenas BioPharma: Obexelimab Is Being Graded On The Wrong Curve (NASDAQ:ZBIO) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 5, 2026 | neutral | 0 | 0.6 |
| Zenas BioPharma (NasdaqGS:ZBIO) Stock Forecast & Analyst Predictions - Simply Wall Street | Zenas BioPharma (NasdaqGS:ZBIO) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 30, 2026 | neutral | 0 | 0.6 |
| $ZBIO stock is down 8% today. Here's what we see in our data. - Quiver Quantitative | $ZBIO stock is down 8% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 24, 2026 | neutral | 0 | 0.6 |
| Zenas BioPharma Grants Inducement Stock Options and RSUs to New Employees - Quiver Quantitative | Zenas BioPharma Grants Inducement Stock Options and RSUs to New Employees Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 17, 2026 | neutral | 0 | 0.6 |
| Zenas BioPharma (ZBIO): Best IPO Stocks with Huge Upside Potential - Yahoo Finance | Zenas BioPharma (ZBIO): Best IPO Stocks with Huge Upside Potential Yahoo Finance | View source ↗ | Yahoo Finance | Jul 10, 2026 | neutral | 0 | 0.6 |
| ZBIO Forecast — Price Target — Prediction for 2027 - TradingView | ZBIO Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Zenas BioPharma, Inc. Common Stock (ZBIO) Stock - Gotrade | Zenas BioPharma, Inc. Common Stock (ZBIO) Stock Gotrade | View source ↗ | Gotrade | Jan 13, 2026 | neutral | 0 | 0.6 |
| Why Is ZBIO Stock Falling Pre-Market Today? - Stocktwits | Why Is ZBIO Stock Falling Pre-Market Today? Stocktwits | View source ↗ | Stocktwits | Jan 6, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.